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cyte mtROS level was the only predictor of endothelial (dys) function.
According to the present hypothesis, low-grade systemic inﬂamma-
tion is the etiopathogenic link between periodontitis and CVD. In addi-
tion to locally produced inﬂammatory mediators, the oral bacterial
challenge contributes to systemic inﬂammation. The ultimate goal of
periodontal treatment is to remove the dysbiotic bioﬁlm in order toInﬂammation
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LipopolysaccharideThe association between periodontitis (Fig. 1), one of themost com-
odontal tissues, lymph vessels, or saliva [3], resulting in endotoxemia.
Endotoxemia is recognized as an independent risk factor for both inci-mon bacterial-induced chronic inﬂammatory diseases in adults, and in-
creased risk for atherosclerotic cardiovascular disease (CVD) is
established, although the evidence that the treatment of periodontitis
would reducemajor adverse events is scarce andmainly circumstantial.
Interestingly, Sen and co-workers [1] published recently that regular
dental care was associated with decreased risk for incident stroke com-
pared to no dental care or episodic care only when symptoms arise.
In the present issue of International Journal of Cardiology, Masi and
co-workers [2] investigated the effect of periodontal treatment on the
formation of mitochondrial reactive oxygen species (mtROS) in a
carefully performed randomized controlled trial of patients with type
2 diabetes. All patients were assigned to treatment due to moderate to
severe periodontitis, and they were randomized to receive either
control or intensive periodontal treatment (IPT). After six months, the
patients in the IPT group presented improvement in interferon-γ
(IFN-γ), tumour necrosis factor-α, and soluble adhesion molecule con-
centrations, aswell asmeasures of lipopolysaccharide (LPS) activity, en-
dothelial function, and metabolic control. Importantly, the IPT group
presented with a lower production of mtROS due to reduced oxidative.2018.05.019.
ses, University of Helsinki, P.O.
en).
eliability and freedom frombiasrestore the host-microbial homeostasis. This treatment needs to be ag-
gressive enough to produce beneﬁcial results both locally and systemi-
cally as reported byMasi and co-workers [2]. One of themajor bacterial-
derived mediators of systemic effects is LPS, an important virulence
factor of gram-negative bacteria, which have a dominance in the
periodontitis-associated microbiota. The translocation of LPS into the
circulation may occur directly or through inﬂamed and bleeding peri-
dent coronary artery disease and diabetes [4]. In the study by Masi
and co-workers [2], serum LPS activity, i.e. endotoxemia, ended up on
a lower level in the IPT than in the control group after the treatment
period.
As a Toll like receptor-ligand, LPS is able to inducemtROS formation
in immune cells. mtROS are involved in pathogen-host interactions
including several pathways crucial for immune responses, such as
apoptosis, autophagy, inﬂammation, and bactericidal effects [5]. Masi
and co-workers [2] detected most pronounced effects of IPT on mtROS
reduction in the lymphocyte fraction. In lymphocytes, as in other
immune cells, superoxide anion radical (O2−°) can be produced by
NADPH oxidase(s) or as a result of electron leakage inmitochondria. Al-
though mtROS were initially considered as toxic by-products of oxida-
tive metabolism, they are continuously generated and, at physiological
levels, regulate essential cellular processes [6].
Amongother sources, complex I and III of themitochondrial electron
transport chain represent major sites of O2−° formation. O2−° is a short-
lived radical and it dismutates to H2O2 and O2 in a reaction occurring
either spontaneously or in a superoxide dismutase-catalysed manner.
In contrast to O2−°, H2O2 is electrically neutral, diffuses across cellular
membranes, and acts as second messenger during lymphocyte activa-
tion [7]. Of note, mtROS production by an intact complex III is required
for T-cell activation and IFN-γ secretion from stimulated leukocytes.
Thus, decreased LPS and mtROS formation could lead to attenuated
IFN-γ secretion as reported [2].
Whether or not the ROS-toxiﬁer myeloperoxidase, which converts
the relatively non-toxic H2O2 to the potent oxidant hypochlorous acid
Fig. 1. Clinical picture of periodontal disease. A gingivitis patient has bleeding gums with
classical signs of inﬂammation: pain, redness, and swelling. Plaque-induced gingivitis is
a reversible state without destruction of connective tissue. Gingivitis may transform into
periodontitis in susceptible individuals and always precedes periodontitis, which is
characterized by an irreversible loss of tooth-supporting tissues. Periodontal diseases are
always diagnosed by a dentist and require professional treatment.
292 Editorial[8], is reduced in patients undergoing ICT was not addressed in the
study by Masi and co-workers [2]. This could be of importance since
the neutrophil proteolytic activation cascade represents an apparent
mechanistic link between periodontitis and coronary heart disease
and high levels of myeloperoxidase, a heme protein abundantly present
in neutrophils, are associated with periodontitis, diabetes, CVD, and
endothelial dysfunction [8,9].
The systemically beneﬁcial effects of periodontal treatment most
likely involve decreased endotoxemia leading to reduction of the
inﬂammatory responses. This affects several pathways involved in
atherogenesis, such as lipoprotein composition and function, glucose
metabolism, complement cascade, contact activation, leukocyte migra-
tion, vascular permeability, and oxidative stress. Indeed, proper peri-
odontal treatment can improve cardiovascular risk factors: according
to a recent meta-analysis plasma concentrations of inﬂammatory,
thrombotic, and metabolic markers decrease and endothelial function
improves [10]. The association between poor oral and general health
has been under intense research for decades. However, counselling
patients on the importance of maintaining good oral health and visiting
dental professionals regularly is only rarely given by cardiologists,
neurologists, or general medical practitioners. Even though chronic
oral infections would not be causally linked with cardiometabolicdisorders, it is time to merge oral health care with the health care of
the rest of the body.
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